From: voanews.com Federal regulators have given approval for U.S. clinical trials of a Cuban-developed lung cancer vaccine. New York Governor Andrew Cuomo announced the Food and Drug Administration’s decision Wednesday at the Roswell Park Cancer Institute in Buffalo. Lung cancer is the second most commonly diagnosed cancer in both men and women, according to the American Cancer Society, which estimates …
Promise of better targeted treatments now possible in children’s brain cancer
Source: University of Utah Health Sciences From: eurekalert.org More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that …
Study Indicates that Advances in Precision Medicine Have Improved Breast Cancer Treatment
A new study examines how one early example of precision medicine—tumor genome testing—is being used in women with breast cancer to reduce overtreatment and maximize the benefits of chemotherapy. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that physician recommendations and final treatment decisions correlated highly with test results, suggesting genome testing …
A Noninvasive Colon Cancer Test That’s FIT To Be Tried
By: Nancy Shute From: npr.org Not so very long ago, colonoscopy was the gold standard for colon cancer screening. But times are a-changing. Last month when I went in for a checkup, my primary care doctor handed me a FIT test, a colon cancer test you can do at home without the unpleasantness and risk that turn people off to …
New study examines how tumor genome testing helps improve breast cancer treatment
Source: Wiley From: news-medical.net A new study examines how one early example of precision medicine–tumor genome testing–is being used in women with breast cancer to reduce overtreatment and maximize the benefits of chemotherapy. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that physician recommendations and final treatment decisions correlated highly with test …
Exclusive: WHO cancer agency asked experts to withhold weedkiller documents
By: Kate Kelland From: reuters.com The World Health Organization’s cancer agency – which is facing criticism over how it classifies carcinogens – advised academic experts on one of its review panels not to disclose documents they were asked to release under United States freedom of information laws. In a letter and an email seen by Reuters, officials from the International …
Study Shows First Practical Intervention for Chemobrain
SAN FRANCISCO, CA (October 31, 2016) – For the first time, symptoms of cancer-related cognitive decline – often called “chemobrain” – were reversed in a large, home-based, randomized controlled trial, using unique computerized brain exercises, according to a report today in the Journal of Clinical Oncology. Breast cancer support groups first brought attention to a phenomenon they called “chemobrain” or …
New test identifies aggressive form of breast cancer
By: Kristen Jordan Shamus From: freep.com A University of Michigan researcher has invented a technology that can take some of the guesswork out of whether one form of early breast cancer is aggressive and likely to metastasize. Dr. Howard Petty, a cancer survivor himself, came up with an imaging technology called Biomarker Ratio Imaging Microscopy — or BRIM — that highlights …
The Case for Changing “Caregiver” for Cancer Patients
View PostDanish researchers behind new cancer images
By: Kim Harel From: ingenioer.au.dk/en A Danish research team is behind a new method for studying how a tracer is distributed in a cancer tumour via its extensive vascular network. The method can be used for purposes such as closely studying the effect of medical treatment using cancer inhibitors. By means of mathematical modelling, the researchers combined two previously known …